DocGo (NASDAQ:DCGO - Get Free Report) will issue its quarterly earnings data after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of $0.04 per share for the quarter. DocGo has set its FY 2024 guidance at EPS.Parties that are interested in participating in the company's conference call can do so using this link.
DocGo (NASDAQ:DCGO - Get Free Report) last posted its earnings results on Wednesday, August 7th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.01). DocGo had a net margin of 3.97% and a return on equity of 8.90%. The company had revenue of $164.95 million for the quarter, compared to the consensus estimate of $166.61 million. On average, analysts expect DocGo to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
DocGo Trading Up 1.4 %
NASDAQ DCGO traded up $0.05 during trading on Thursday, hitting $3.51. 546,430 shares of the company traded hands, compared to its average volume of 1,013,418. DocGo has a 12 month low of $2.75 and a 12 month high of $6.90. The business has a fifty day simple moving average of $3.45 and a 200 day simple moving average of $3.31. The company has a market capitalization of $359.13 million, a P/E ratio of 12.50, a PEG ratio of 2.91 and a beta of 0.91.
Analyst Ratings Changes
DCGO has been the topic of several recent research reports. Needham & Company LLC restated a "buy" rating and set a $7.00 target price on shares of DocGo in a report on Thursday, August 8th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $5.00 price target on shares of DocGo in a research report on Friday, September 20th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat, DocGo presently has an average rating of "Buy" and a consensus price target of $6.10.
View Our Latest Research Report on DCGO
About DocGo
(
Get Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Featured Stories
Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
